Armas Pharmaceuticals launches first injectable in US with Vidaza generic
Armas Pharmaceuticals has entered the US injectable drug market with its launch of Azacitidine for Injection 100 MG, a generic version of Vidaza, targeting myelodysplastic ... Read More